Profil
Katie Sullivan is currently working as the Senior Director-Corporate Communications at Gelesis, Inc. since 2020.
Prior to this, she worked as the Head-Media Contact at Gelesis Holdings, Inc.
Postes actifs de Katie Sullivan
| Sociétés | Poste | Début |
|---|---|---|
| GELESIS INC | Public Communications Contact | 01/02/2020 |
Anciens postes connus de Katie Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
| GELESIS HOLDINGS, INC. | Public Communications Contact | 30/10/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
